Theralase Technologies Inc. V.TLT

Interesting perspective

[DJDawg]

Hi
I had mentioned this company to a friend, whose husband is a type A kind of research person and it was interesting hear his perspective.

His concerns were as follows:
- penny stock price that his highly volatile in price.
- a glass door employee rating from 2017 that mentioned a dysfunctional workplace where the husband and wife owners have loud disagreements all the time. And who micromanage everything without realizing that they don't know everything.
- rapid CEO changeover (2 in the past 6 months alone)
- analyst ratings as a "speculative" play

He said it seems like a terrible idea to invest.

I found it fascinating as I completely agree. Everything I've read sounds like the leadership issues are big. It is speculative to a degree. The CEO changeover issues don't inspire faith at all.

I guess my only personal faith is that no matter how badly run the company is, if they are recruiting patients via the supporting centres, giving them the drug at a good dose and procedure at a good dose, that is what counts. Thankfully we are not relying on RDW's word regarding the medical results as those are controlled by the academic urologists rather than the corporate leadership. I have faith in some of the names on the med adv board and have faith in Vera and her background.

But overall, I can totally see why so many people will stay away a bit longer. Need the BTD to breakout I think.

Just in interesing perspective from my friend's husband. Thought I would share.

DJ

[floatinketucky]

And did what did they conclude of the science? Like the CR rates? The BTD?  Like the phase 2 trial being PIVITOL? The actual buisness/SCIENCE of the company?

[menoalittle]

>> The actual buisness/SCIENCE of the company? In short, it's simply not understood well enough to be believable to most people.

[floatinketucky]

Like who cares about the paint job, Can the vehicle get to the next buisness goal? The science seems clearly to be showing it very very likely. I thinik this is a good truck. 

[DJDawg]

Hey I'm with you guys. But I'm just pointing out that there is a mass of investors that are not getting to this stock (yet) because it has issues, hopefully more in the past. Even reading the CR results is confusing because there is optimized and non-optimized because they messed up and underdosed a bunch of patients AND removed them from the trial prematurely. The plus side is that if

[fredgoodwinson]

Here primarily for what x-ray activated Rutherrin may do against deep cancers but in addition to NMIBC there are many superficial cancers with less than satisfactory outcomes for which TLD-1433 may prove suitable.   Difficult to reconcile the thin-ness of the buy side at these modest levels with the Clinical data from the last Newsletter but continue to add.  

[menoalittle]

>> Difficult to reconcile the thin-ness of the buy side at these modest levels  it's because everything between 20 and 35 cents has already vacuumed up. only mere tidbits remain... (until the next 15 cent step up.) 

[robertshaw]

count on blowjobjoe's bosses selling more cheapies...

[menoalittle]

>> count on blowjobjoe's bosses selling more cheapies... well... what are they waiting for? Christmas ?

[robertshaw]

Here comes the Blowjobjoe's bosses' dumping as we expected.., But I guess less long shareholders dare to buy now as brave guys like Lesalpes29 and Sunvalley just did...

[floatinketucky]

If the stock maintains a quarter or so by the next release...

[fredgoodwinson]

TBH with the way they twist the market find that less surprising than there being only 1500 on the bid at 33.5,

[menoalittle]

ya, well... try not to be fooled by that wee little (iceberg's) size. I've seen 'em able to swallow a river.  

[VerusSemperSors]

It is a volatile, speculative, clinical-stage penny stock with periodic management conflicts. They do seem to have the goods. And management conflicts affect companies of all sizes. There's not enough total value for professional advisors to recommend it to their clients. Many of the retail investors that might stumble upon it on their own would not consider buying a speculative penny stock.

[floatinketucky]

I expect a move to .50 cents+ will be brought on more by price discovry individual investers  rather than professionaly advised investers. 

[menoalittle]

>> I expect a move to .50 cents+ will be brought on more by price discovry individual investers  rather than professionaly advised investers. more than professionally advised? okay, sure. there's always a few that stumble upon it. however, I surmise that the next step up will be primarily driven by the deep pockets of those already "in the know," as they continue to

[floatinketucky]

Let's talk Dec 2nd buying. TLTFF action consisted of 626,028 shares sold that day with 408,197 shorted. Dec 2nd opened at .2066 and closed at .2592. I think the principal buying came from let's say Data aware private investors, who expect in the near term the stock price will rise. So they wanted to get them shares.   Let's talk Dec 3. TLTFF action consisted of 1,038,430

[Galaxym31]

Aggresive bashing B + .